secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K/A
Filed at:   2025-02-10T23:59:59+00:00
Accession:  0001493152-25-005699
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics files 8-K/A to add auditor consent to Jan 10 filing
--------------------------------------------------------------------------

- Amendment solely adds Exhibit 23.1, consent of Marcum LLP.
- No modifications to prior 8-K disclosure; no new financial or operational data.
- Filing date Feb 10, 2025; original report filed Jan 10, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315225005699/0001493152-25-005699-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315225005699/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-005699

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer